IOL Chemicals & Pharmaceuticals has informed that the Independent Directors in their meeting held on today i.e. 12 February 2018 reviewed the performance of non-independent directors and the Board as a whole; reviewed the performance of the Chairman of the company and assessed the quality, quantity and timeliness of flow of information between the company management and the Board in line with the requirements of Regulation 25 of the SEBI(Listing Obligations and Disclosure Requirements) Regulations, 2015 read with applicable provisions of Schedule IV of the Companies Act, 2013.
The above information is a part of company’s filings submitted to BSE.
